FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Akums Drugs and Pharmaceuticals IPO and Interarch Building Products IPO.
Akums Drugs and Pharmaceuticals IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Interarch Building Products IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Akums Drugs and Pharmaceuticals IPO | Interarch Building Products IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | ICICI Securities Limited Axis Bank Limited Citigroup Global Markets India Private Limited Ambit Private Limited |
Ambit Private Limited Axis Capital Limited |
Registrar | Link Intime India Private Ltd | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Akums Drugs and Pharmaceuticals IPO is up to ₹1,856.74 Cr whereas the issue size of the Interarch Building Products IPO is up to ₹600.29 Cr. The final issue price of Akums Drugs and Pharmaceuticals IPO is ₹679.00 per share and of Interarch Building Products IPO is ₹900.00 per share.
Akums Drugs and Pharmaceuticals IPO | Interarch Building Products IPO | |
---|---|---|
Face Value | ₹2 per share | ₹10 per share |
Issue Price (Lower) | ₹646.00 per share | ₹850.00 per share |
Issue Price (Upper) | ₹679.00 per share | ₹900.00 per share |
Issue Price (Final) | ₹679.00 per share | ₹900.00 per share |
Discount (Retail) | ||
Discount (Employee) | ₹64.00 per share | ₹85.00 per share |
Market Lot Size | 22 shares | 16 shares |
Fresh Issue Size | 1,00,14,727 shares | 22,22,222 shares |
Fresh Issue Size (Amount) | up to ₹680.00 Cr | up to ₹200.00 Cr |
OFS Issue Size | 1,73,30,435 shares | 44,47,630 shares |
OFS Issue Size (Amount) | up to ₹1,176.74 Cr | up to ₹400.29 Cr |
Issue Size Total | 2,73,45,162 shares | 66,69,852 shares |
Issue Size Total (Amount) | up to ₹1,856.74 Cr | up to ₹600.29 Cr |
Akums Drugs and Pharmaceuticals IPO opens on Jul 30, 2024, while Interarch Building Products IPO opens on Aug 19, 2024. The closing date of Akums Drugs and Pharmaceuticals IPO and Interarch Building Products IPO is Aug 01, 2024, and Aug 21, 2024, respectively.
Akums Drugs and Pharmaceuticals IPO | Interarch Building Products IPO | |
---|---|---|
Anchor Bid Date | Jul 29, 2024 | Aug 16, 2024 |
Issue Open | Jul 30, 2024 | Aug 19, 2024 |
Issue Close | Aug 01, 2024 | Aug 21, 2024 |
Basis Of Allotment (Tentative) | Aug 02, 2024 | Aug 22, 2024 |
Initiation of Refunds (Tentative) | Aug 05, 2024 | Aug 23, 2024 |
Credit of Share (Tentative) | Aug 05, 2024 | Aug 23, 2024 |
Listing date (Tentative) | Aug 06, 2024 | Aug 26, 2024 |
Anchor Lockin End date 1 | Sep 01, 2024 | Sep 21, 2024 |
Anchor Lockin End date 2 | Oct 31, 2024 | Nov 20, 2024 |
Akums Drugs and Pharmaceuticals IPO P/E ratio is , as compared to Interarch Building Products IPO P/E ratio of 15.04.
Akums Drugs and Pharmaceuticals IPO | Interarch Building Products IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Akums Drugs and Pharmaceuticals Limited Financial Information (Restated Consolidated)Akums Drugs and Pharmaceuticals Limited's revenue increased by 13.81% and profit after tax (PAT) dropped by -99.19% between the financial year ending with March 31, 2024 and March 31, 2023.
|
Interarch Building Products Limited Financial Information (Restated)Interarch Building Products Limited's revenue increased by 15% and profit after tax (PAT) rose by 6% between the financial year ending with March 31, 2024 and March 31, 2023.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 84.94% | 87.53% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 59.9% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 15.04 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹1497.43 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 0.11%% | 19.40%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 3.37%% | 25.79%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.69 | -0.11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹59.84 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | -0.57% | 22.26%% |
In the Akums Drugs and Pharmaceuticals IPO retail investors (RII) are offered 27,12,424 shares while in Interarch Building Products IPO retail investors are offered 27,12,424 shares. Qualified institutional buyers (QIB) are offered 81,37,276 shares in Akums Drugs and Pharmaceuticals IPO and 13,29,526 shares in Interarch Building Products IPO.
Akums Drugs and Pharmaceuticals IPO | Interarch Building Products IPO | |
---|---|---|
Anchor Investor Reserveration | 1,22,05,912 shares | 19,94,288 shares |
Market Maker Reserveration | ||
QIB | 81,37,276 shares | 13,29,526 shares |
NII | 40,68,637 shares | 9,97,145 shares |
RII | 27,12,424 shares | 23,26,671 shares |
Employee | 2,43,902 shares | 24,539 shares |
Others | ||
Total | 1,51,62,239 shares | 46,77,881 shares |
Akums Drugs and Pharmaceuticals IPO subscribed 63.44x in total, whereas Interarch Building Products IPO subscribed 93.79x.
Akums Drugs and Pharmaceuticals IPO | Interarch Building Products IPO | |
---|---|---|
QIB (times) | 90.09x | 197.29x |
NII (times) | 42.10x | 130.91x |
Big NII (times) | 47.43x | 148.31x |
Small NII (times) | 31.45x | 96.11x |
RII (times) | 20.80x | 19.46x |
Employee (times) | 4.14x | 25.75x |
Other (times) | ||
Total (times) | 63.44x | 93.79x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|